Edition:
United Kingdom

Innovate Biopharmaceuticals Inc (INNT.OQ)

INNT.OQ on NASDAQ Stock Exchange Capital Market

25.00USD
18 Apr 2018
Change (% chg)

$-5.05 (-16.81%)
Prev Close
$30.05
Open
$29.08
Day's High
$29.08
Day's Low
$24.78
Volume
111,701
Avg. Vol
55,218
52-wk High
$50.50
52-wk Low
$3.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.61 -2.953
Sep '17 0.14 -1.611
Jun '17 0.19 -1.939
Mar '17 0.95 -2.804
FY 2016 Dec '16 1.07 -1.586
Sep '16 0.78 -2.655
Jun '16 1.68 -1.538
Mar '16 0.54 -2.333
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.05 32.74
P/E High - Last 5 Yrs. -- 293.18 45.72
P/E Low - Last 5 Yrs. -- 91.59 24.22
Beta -- 0.90 0.88
Price to Sales (TTM) 1.94 110.91 5.71
Price to Book (MRQ) -- 13.58 5.37
Price to Tangible Book (MRQ) -- 14.04 6.95
Price to Cash Flow (TTM) -- 71.43 23.32
% Owned Institutions 1.38 12.76 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -88.89 399.23 9.21
Sales (TTM) vs TTM 1 Yr. Ago -61.60 78.85 5.69
Sales - 5 Yr. Growth Rate -- 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -26.12 25.02 19.36
EPS (TTM) vs TTM 1 Yr. Ago 4.49 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.76
Capital Spending - 5 Yr. Growth Rate -- 40.30 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.15 1.80 2.19
Current Ratio (MRQ) 0.31 5.30 2.98
LT Debt to Equity (MRQ) -- 22.97 12.18
Total Debt to Equity (MRQ) -- 24.63 16.45
Interest Coverage (TTM) -3.93 -99.38 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 5.80 40.03 54.44
Gross Margin - 5 Yr. Avg. -- 51.15 52.20
EBITD Margin (TTM) -248.84 -- --
EBITD - 5 Yr. Avg -- -574.95 10.96
Operating Margin (TTM) -232.32 -718.73 4.73
Operating Margin - 5 Yr. Avg. -- -596.27 6.40
Pre-Tax Margin (TTM) -233.62 -693.19 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.63 6.81
Net Profit Margin (TTM) -233.69 -694.42 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.48 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,634,794 846,834,920
Net Income/Employee (TTM) -- 2,972,499 99,616,660
Receivable Turnover (TTM) 4.77 20.16 5.78
Inventory Turnover (TTM) 3.44 2.37 3.35
Asset Turnover (TTM) 0.63 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -147.16 -1.10 10.95
Return on Assets - 5 Yr. Avg. -- -0.57 12.31
Return on Investment (TTM) -- 1.59 14.38
Return on Investment - 5 Yr. Avg. -- 2.21 16.10
Return on Equity (TTM) -- 2.42 16.07
Return on Equity - 5 Yr. Avg. -- 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -50.82 5.68 --
EPS (TTM) % -3.76 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Innovate Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.14%
# of Holders: 9
Total Shares Held: 32,273
3 Mo. Net Change: 4,403
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.